Home Details
| Official Symbol of Gene | IL6 |
| Species | Homo sapiens |
| Entrez Gene ID | 3569 |
| Official Full Name | interleukin 6 |
| Also known as | CDF; HGF; HSF; BSF2; IL-6; BSF-2; IFNB2; IFN-beta-2 |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000136244 MIM:147620; AllianceGenome:HGNC:6018 |
| Map Location | 7p15.3 |
| Variation Type | SNP |
| refSNP ID | rs1800796 |
| Detected Sample | blood or saliva |
| Sample Detail | Genomic DNA sample |
| Detected Method | PCR |
| Disease | MS |
| Disease subtype | RRMS,SPMS,PPMS |
| Population | The MS patients were all recruited by the Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene).Healthy controls were recruited from Royal Brisbane and Women’s Hospital or University of Queensland staff. |
| Sample Size | 509 patients/279 controls |
| Pubmed ID | 23202972 |
| Year | 2012 |
| Title | Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis |
| Risk Type | Disease risk |
| Main Result | Positive |
| Result | Patients with the 572 GC genotype overall showed a significantly higher median MSSS than did those with the GG genotype. |
| Mechanism/Pathway | N/A |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.